Stock Events

Stock Events

Mezzion PharmaLtd. 

₩69,000
4
+₩2,800+4.23% 06:30 Today

Statistics

Day High
71,100
Day Low
65,300
52W High
179,900
52W Low
45,850
Volume
91,224
Avg. Volume
128,733
Mkt Cap
2.11T
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 13
₩13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q2 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-604.19
-603.86
-603.52
-603.19
Expected EPS
N/A
Actual EPS
N/A

Financials

-441.61%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
7.91BRevenue
-34.93BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 140410.KQ. It's not an investment recommendation.
Bitcoin
2
BTC.CRYPTO
Ethereum
2
ETH.CRYPTO
POSCO
2
005490.KQ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap162.16B
Pfizer is a global pharmaceutical company that competes with Mezzion Pharma in the development and marketing of drugs for various therapeutic areas, including cardiovascular diseases.
Novartis
NVS
Mkt Cap304.1B
Novartis is a multinational pharmaceutical company that competes across several therapeutic areas similar to Mezzion Pharma, including heart disease treatments.
Merck
MRK
Mkt Cap370.89B
Merck is a leading pharmaceutical company that develops medicines across many areas, including those that overlap with Mezzion Pharma's focus on cardiovascular diseases.
GSK
GSK
Mkt Cap99.96B
GlaxoSmithKline is a global healthcare company that competes with Mezzion Pharma in the development of pharmaceuticals and vaccines for various diseases, including heart-related conditions.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie operates in multiple therapeutic areas, including cardiovascular diseases, making it a competitor to Mezzion Pharma in the pharmaceutical industry.
AMGEN
AMGN
Mkt Cap236.38B
Amgen is a biopharmaceutical company that competes with Mezzion Pharma in developing treatments for cardiovascular diseases among other areas.
Bristol-Myers Squibb
BMY
Mkt Cap136.49B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Mezzion Pharma in several therapeutic areas, including cardiovascular diseases.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company that competes with Mezzion Pharma in developing treatments for various diseases, including those related to the heart.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson is a diversified healthcare company that competes with Mezzion Pharma in the pharmaceutical sector, including the development of cardiovascular drugs.
Sanofi
SNY
Mkt Cap106.01B
Sanofi is a global healthcare leader that competes with Mezzion Pharma in the development and marketing of pharmaceuticals for a broad range of diseases, including cardiovascular conditions.

About

Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.
Show more...
CEO
Dong-Hyun Park
Employees
18
Country
South Korea
ISIN
KR7140410002

Listings

KQ
KR
140410.KQ

0 Comments

Share your thoughts

FAQ

What is Mezzion PharmaLtd. stock price today?▼
The current price of 140410.KQ is ₩69,000 KRW — it has increased by +4.23% in the past 24 hours. Watch Mezzion PharmaLtd. stock price performance more closely on the chart.
What is Mezzion PharmaLtd. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Mezzion PharmaLtd. stocks are traded under the ticker 140410.KQ.
Is Mezzion PharmaLtd. stock price growing?▼
140410.KQ stock has risen by +3.76% compared to the previous week, the month change is a +26.61% rise, over the last year Mezzion PharmaLtd. has showed a +23.66% increase.
What is Mezzion PharmaLtd. market cap?▼
Today Mezzion PharmaLtd. has the market capitalization of 2.11T
What is Mezzion PharmaLtd. revenue for the last year?▼
Mezzion PharmaLtd. revenue for the last year amounts to 7.91B KRW.
What is Mezzion PharmaLtd. net income for the last year?▼
140410.KQ net income for the last year is -34.93B KRW.
Does Mezzion PharmaLtd. pay dividends?▼
Yes, 140410.KQ dividends are paid annual. The last dividend per share was 12.5 KRW. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Mezzion PharmaLtd. have?▼
As of September 08, 2026, the company has 18 employees.
In which sector is Mezzion PharmaLtd. located?▼
Mezzion PharmaLtd. operates in the Health & Wellness sector.
When did Mezzion PharmaLtd. complete a stock split?▼
The last stock split for Mezzion PharmaLtd. was on April 05, 2022 with a ratio of 2:1.
Where is Mezzion PharmaLtd. headquartered?▼
Mezzion PharmaLtd. is headquartered in Seoul, South Korea.